+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genetic Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 573 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338531
Description Jump to:
The global market for Genetic Testing is estimated at US$13 Billion in 2023 and is projected to reach US$24.8 Billion by 2030, growing at a CAGR of 8.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Prenatal & Newborn Genetic Testing segment, which is expected to reach US$8.4 Billion by 2030 with a CAGR of 8.6%. The Diagnostic segment is also set to grow at 8% CAGR over the next 8 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $5.5 Billion in 2023, and China, forecasted to grow at an impressive 10.4% CAGR to reach $2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Genetic Testing Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Genetic Testing Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Genetic Testing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Asuragen, Inc., Biocartis NV, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 249 Featured):

  • Agilent Technologies, Inc.
  • Asuragen, Inc.
  • Biocartis NV
  • Agena Bioscience, Inc.
  • ARUP Laboratories
  • Bioiberica SAU
  • AutoGenomics, Inc.
  • Biodesix, Inc.
  • Admera Health
  • Annoroad Gene Technology
  • Berry Genomics Co., Ltd.
  • Ariel Precision Medicine, Inc.
  • AlphaBiolabs Ltd.
  • AnchorDx
  • Alexian Brothers of America, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Genetic Testing - Global Key Competitors Percentage Market Share in 2023 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
  • A Prelude to Genetic Testing
  • Top Ten Genetic Diseases Worldwide
  • Different Types of Genetic Tests include
  • Prenatal and Newborn Screening
  • Diagnostic Testing
  • Predictive & Presymptomatic Testing
  • Carrier Identification
  • Pharmacogenomic Testing
  • List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
  • Genetic Testing Delivery Models
  • Genetic Sequencing Approaches
  • Expanding Applications to Drive Genetic Testing Market
  • Regional Landscape
  • Prenatal Testing Market to Rise
  • Market Outlook
2. FOCUS ON SELECT PLAYERS
  • Recent Market Activity
  • World Brands
  • Innovations
3. MARKET TRENDS & DRIVERS
  • Studies Indicate Possible Correlation between Genetic Variations Tied to Immunity and COVID-19 Severity
  • SEGMENT ANALYSIS
  • Prenatal Testing - Changing the World of Pregnancy Care
  • List of Available Prenatal Screening and Diagnostic Tests by Indication
  • Players in the Prenatal and New Born Genetic Testing Market
  • Conventional Invasive Pre-Natal Diagnostic Techniques - A Risky Affair
  • Emergence of Non-Invasive Prenatal Diagnosis (NIPD)
  • Competition Intensifies in the NIPD Market
  • Select Commercially Available NIPD (Genetic) Tests for Aneuploidy in the US
  • Strain on Resources Prevent Wide Adoption of Expanded Carrier Sequencing
  • Predictive Diagnostics
  • Breast Cancer Gene Testing Market to Expand Strongly
  • Myriad Genetics - A Leader in Breast Cancer Testing
  • Discovery of Novel Biomarkers Crucial to Predictive Diagnostics
  • Pharmacogenomics Development Augurs Growth of Genetic Testing Market
  • MARKET TRENDS AND GROWTH DRIVERS
  • Genetic Testing Paves the Way for Personalized Medicine
  • Next-Generation Sequencing (NGS) - A Giant Leap in Genome Sequencing
  • Biomarker Discovery Leads to Advanced Genetic Testing
  • Select List of Available Tumor Markers
  • Immense Popularity of Ancestry Testing
  • Increasing Focus on Data Churning
  • Genetic Testing to Explode into Provider Workflow with Intriguing Use Cases
  • Primary Factors Responsible for Waning Interest in Direct-to Consumer Genetic Testing
  • Liquid Biopsy to Facilitate Cancer Diagnosis and Treatment
  • Hybrid Labs to Bridge Gap Between Traditional and DTC Models
  • Rising Prevalence of Cancer and Chromosomal Disorders Augments Demand for Cell-Free DNA Testing
  • Emergence of Rapid DNA Testing
  • Oncology - A Key Focus Area for Genetic Testing
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Ageing Demographics to Drive Demand for Genetic Testing
  • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Prenatal & Newborn by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Prenatal & Newborn by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Prenatal & Newborn by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Predictive & Presymptomatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Predictive & Presymptomatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Predictive & Presymptomatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Carrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Carrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Carrier by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Pharmacogenomic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Pharmacogenomic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Pharmacogenomic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Genetic Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 26: World Historic Review for Genetic Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 27: World 16-Year Perspective for Genetic Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Cardiovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 29: World Historic Review for Cardiovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 30: World 16-Year Perspective for Cardiovascular Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 33: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 34: World Genetic Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Use of Genomic Data in Clinical Settings to Gather Pace
  • The United States: Leading Market for Genetic Testing Globally
  • Predictive Screening: Another Growth Area
  • Growing Relevance of Personalized Medicine Augurs Well
  • Rising Incidence of Cancer in the US: Driver for Cancer Genetic Testing
  • Newborn Testing Gains Ground
  • Invasive Prenatal Diagnosis Gives Way to Non-Invasive Prenatal Testing
  • Coverage of NIPT in Average Risk Pregnancies Expands Target Market
  • Direct-to-Consumer Testing: A Growing Market
  • Favorable Reimbursement Policies
  • Favorable Insurance Coverage for Cystic Fibrosis Genetic Testing
  • Demographic Changes Offer Growth Opportunities
  • Skepticism Limits Widespread Adoption of Genetic Testing
  • Competitive Overview
  • Myriad Eyes Diversification and Expansion for Growth
  • Natera Holds Fort in the NIPT Market
  • Invitae Banks on Low Cost Solutions for Expanding Revenues
  • Regulatory Environment
  • Genetic Information Nondiscrimination Act Boosts Genetic Testing
  • Stricter Regulations for DTC Genetic Testing
  • FDA Attempts to Put a Leash around Unapproved DTC Genetic Tests
  • Select Genetic Test Reimbursement Codes
  • Market Analytics
CANADA
  • Rising Incidence of Chronic Diseases Spurs Genetic Testing Demand
  • Regulatory Scenario
  • Market Analytics
JAPAN
  • Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Demographics Drive Market Growth
  • DTC Genetic Testing Regulatory Scenario
CHINA
  • Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Market Overview
  • China Attracts Domestic and Foreign Players
  • Strong Focus on Genomics
  • Genetic Testing to Reveal Real Talent in Children - A New Popular Application
  • China to Take Lead in Rapidly Growing Asian Genomics Market
  • Market Analytics
EUROPE
  • Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • European Personalized Medicine Market to Exhibit Robust Growth
  • Aging Population to Drive Demand for Genetic Testing
  • Legislations/Regulatory Policies in Select European Countries
  • Legislations Governing Genetic Testing in Select European Countries
  • Rising Cancer Incidence Augurs Well for European Genetic Testing Market
FRANCE
  • Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Parliamentary Regulations
ITALY
UNITED KINGDOM
  • Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Increased Support for Personalized Medicine to Drive Genetic Testing
  • SMIP for Pharmacogenomic Testing
  • Increasing Need for Less Risky Prenatal Diagnostic Methods in the UK
  • Principles for DTC Genetic Testing Laid out by HGC
REST OF EUROPE
ASIA-PACIFIC
  • Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Healthcare Spending in Asia-Pacific: On the Rise
  • India
  • Australia and New Zealand
  • Market Analytics
REST OF WORLD
  • Predictive Screening: Another Growth Area
  • Market Analytics
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • Asuragen, Inc.
  • Biocartis NV
  • Agena Bioscience, Inc.
  • ARUP Laboratories
  • Bioiberica SAU
  • AutoGenomics, Inc.
  • Biodesix, Inc.
  • Admera Health
  • Annoroad Gene Technology
  • Berry Genomics Co., Ltd.
  • Ariel Precision Medicine, Inc.
  • AlphaBiolabs Ltd.
  • AnchorDx
  • Alexian Brothers of America, Inc.

Table Information

Report AttributeDetails
No. of Pages573
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 13 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.8 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal

Related Topics

Related Reports

Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report - Product Image

Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Preimplantation Genetic Testing - Global Strategic Business Report - Product Image

Preimplantation Genetic Testing - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Prenatal and Newborn Genetic Testing Global Market Report 2024 - Product Image

Prenatal and Newborn Genetic Testing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Genetic Testing Services Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type, Disease, Service Provider, and Geography - Product Image

Genetic Testing Services Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type, Disease, Service Provider, and Geography

  • Report
  • 193 Pages
  • Global
From
Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2023-2028 - Product Image

Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2023-2028

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.